| Closed |
SWOG-8943 |
Evaluation of Merbarone in Advanced Soft-Tissue Sarcomas |
12/15/1989 |
7/1/1991 |
100% |
|
Published
|
| Closed |
SWOG-8906 |
Evaluation of Merbarone in Hepatoma, Phase II |
2/1/1990 |
5/1/1992 |
63% |
|
Published
|
| Closed |
SWOG-8913 |
Evaluation of Merbarone in Malignant Melanoma, Phase II |
9/1/1991 |
6/15/1993 |
100% |
|
Published
|
| Closed |
SWOG-8916 |
Evaluation of Merbarone in Pancreatic Adenocarcinoma |
3/15/1990 |
6/15/1991 |
86% |
|
Published
|
| Closed |
SWOG-8929 |
Evaluation of Merbarone in Patients with Advanced Renal Cell Carcinoma |
4/15/1990 |
8/1/1992 |
100% |
|
Published
|
| Closed |
SWOG-8042 |
Evaluation of MGBG in Pancreatic Adenocarcinoma |
1/28/1981 |
5/5/1982 |
|
|
Published
|
| Closed |
SWOG-7936 |
Evaluation of Mitomycin-C + Vincristine + Bleomycin + Cis-Platinum vs. Mitomycin-C + Cis-Platinum in the Treatment of Disseminated Carcinoma of the Uterine Cervix |
11/19/1979 |
11/14/1983 |
|
|
Published
|
| Closed |
SWOG-7931 |
Evaluation of n-AMSA in Metastatic or Advanced Adenocarcinoma of the Stomach and Pancreas |
10/5/1979 |
4/14/1981 |
|
|
Published
|
| Closed |
SWOG-9521 |
Evaluation of Nuclear p53 in Patients with Epithelial Ovarian Cancer Patients Registered to SWOG-8835, Ancillary |
3/1/1996 |
11/1/1998 |
|
|
Published
|
| Closed |
SWOG-8800 |
Evaluation of Pibenzimol in Advanced Pancreatic Adenocarcinoma |
4/1/1988 |
5/1/1989 |
|
|
Published
|
| Closed |
SWOG-8866 |
Evaluation of Piroxantrone in Advanced and Metastatic (Stage IV) Non-Small Cell Lung Cancer |
3/1/1990 |
5/1/1991 |
49% |
|
Published
|
| Closed |
SWOG-9116 |
Evaluation of Piroxantrone in Disseminated Malignant Melanoma, Phase II |
6/1/1992 |
10/1/1993 |
100% |
|
Published
|
| Closed |
SWOG-8936 |
Evaluation of Piroxantrone in Gastric Carcinoma |
11/1/1990 |
6/15/1992 |
77% |
|
Published
|
| Closed |
SWOG-8933 |
Evaluation of Piroxantrone in Pancreatic Adenocarcinoma |
9/1/1990 |
9/15/1991 |
100% |
|
Published
|
| Closed |
SWOG-8945 |
Evaluation of Piroxantrone in Patients with Advanced Renal Cell Carcinoma |
9/1/1990 |
5/1/1991 |
76% |
|
Published
|
| Closed |
SWOG-8932 |
Evaluation of Piroxantrone in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck |
4/1/1990 |
7/15/2009 |
80% |
|
Published
|
| Closed |
SWOG-8911 |
Evaluation of Piroxantrone in Refractory Carcinoma of the Breast |
7/1/1990 |
5/15/1993 |
72% |
|
Published
|
| Closed |
SWOG-9505 |
Evaluation of Pyrazine Diazohydroxide in Patients with Disseminated Malignant Melanoma and No Prior Chemotherapy, Phase II |
1/1/1996 |
8/15/1997 |
55% |
|
Published
|
| Closed |
SWOG-9045 |
Evaluation of Quality of Life in Patients with Advanced Colorectal Cancer Enrolled on SWOG-8905 |
3/1/1991 |
1/15/1993 |
|
|
Published
|
| Closed |
SWOG-8994 (EST-C-0690) (INT-0086) |
Evaluation of Quality of Life in Patients with Stage C Adenocarcinoma of the Prostate Enrolled on SWOG-8794 (INT-0086) |
2/15/1990 |
1/1/1997 |
|
|
Published
|
